President Donald Trump

The president criticized the FDA this week for not giving emergency use approval to an experimental treatment for COVID-19. Scientists argue that the therapy still lacks sufficient evidence.

A flurry of executive actions from the president aim to provide pandemic relief to millions of cash-trapped Americans. But how effective will they be and how likely are they to face legal challenges?

It's been two weeks since the president signed an executive order to put "America First" on drug prices. But pharmaceutical companies aren't ready to negotiate.

The administration awarded a contract for a COVID-19 database to TeleTracking Technologies using a process reserved for innovative research. Its CEO had links to the New York real estate world.

The president says the actions will lower drug prices, but policy experts say they will likely offer patients only minimal relief and may take months to implement, if they're implemented at all.

The president took to the briefing room podium for the second time this week, without being joined by members of the White House coronavirus task force.

The solo briefing came as cases of COVID-19 continue to surge in hot spots across the country.

The Trump administration on Tuesday rescinded rules that could have put thousands of foreign students in Florida at risk of deportation if their fall…

President Trump shares a tweet from game show host Chuck Woolery, who claimed the CDC is lying about the coronavirus pandemic to hurt the president in November's election.

In a letter to the U.N., the president said the United States will terminate its relationship with the World Health Organization effective July 6, 2021. He was met with a barrage of criticism.